Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 519

Results For "AP"

7944 News Found

Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline
News | April 17, 2023

Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline

Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology


Molbio Diagnostics and SigTuple join hands to build next-gen diagnostic testing devices
Clinical Trials | April 17, 2023

Molbio Diagnostics and SigTuple join hands to build next-gen diagnostic testing devices

The blood test market worldwide is today around $75-80 billion


CII co-organizes Digital Health Summit 2023 with Health Ministry
Digitisation | April 17, 2023

CII co-organizes Digital Health Summit 2023 with Health Ministry

The Theme of the event was 'Building One Health Together – Improving Health Equity'


G 20: 2nd Health Working Group Meeting discusses global collaboration in research and regional manufacturing for diagnostics
News | April 17, 2023

G 20: 2nd Health Working Group Meeting discusses global collaboration in research and regional manufacturing for diagnostics

The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics


Chiesi Farmaceutici completes acquisition of Amryt Pharma
News | April 15, 2023

Chiesi Farmaceutici completes acquisition of Amryt Pharma

Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.


Fibe partners with Pristyn Care to power affordable quality healthcare across India
Healthcare | April 15, 2023

Fibe partners with Pristyn Care to power affordable quality healthcare across India

Affordability is key to providing accessible healthcare for Bharat.


NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate
Drug Approval | April 15, 2023

NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate

Study efficacy measures will include the expression of dystrophin protein and motor function.


Alpenglow Biosciences and Mayo Clinic collaborate to advance pathology and drug development through 3D spatial biology
Clinical Trials | April 15, 2023

Alpenglow Biosciences and Mayo Clinic collaborate to advance pathology and drug development through 3D spatial biology

Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging


Taros Chemicals and Welab Barcelona partner for drug Discovery and development services
News | April 15, 2023

Taros Chemicals and Welab Barcelona partner for drug Discovery and development services

The combination will support clients in getting their end-to-end discovery and development programs delivered.


Digital Health: An opportunity to increase health equity
Digitisation | April 14, 2023

Digital Health: An opportunity to increase health equity

Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%